Literature DB >> 17583825

Curcumin decreases acid sphingomyelinase activity in colon cancer Caco-2 cells.

Yajun Cheng1, Agnieszka Kozubek, Lena Ohlsson, Berit Sternby, Rui-Dong Duan.   

Abstract

Curcumin has been shown to inhibit cell growth and induce apoptosis in colon cancer cells. The metabolism of sphingomyelin has implications in the development of colon cancert. We examined whether curcumin affects the enzymes that hydrolyse sphingomyelin in Caco-2 cells. The cells were cultured in both monolayer and polarized conditions and stimulated with curcumin. The activities of sphingomyelinases were determined. Sphingomyelin and its hydrolytic products were analysed by thin layer chromatography. The changes of acid sphingomyelinase protein were examined by Western blotting. We found that curcumin reduced the hydrolytic capacity of the cells against choline-labelled sphingomyelin, associated with a mild increase of cellular sphingomyelin in the cells. Analysis of the hydrolytic products revealed that the activity was derived from acid sphingomyelinase not from phospholipase D. The curcumin-induced reduction of acid SMase required more than 8 h stimulation. Western blotting showed reduced acid sphingomyelinase protein after curcumin stimulation. The inhibitory effect was more potent in monolayer cells than in polarised cells. No changes of other sphingomyelinases were identified. In the concentrations inhibiting acid sphingomyelinase, curcumin inhibited DNA synthesis and induced cell death. In conclusion, curcumin inhibits acid sphingomyelinase and the effect might be involved in its antiproliferative property against colon cancer cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17583825     DOI: 10.1055/s-2007-981540

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  8 in total

1.  Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.

Authors:  Robert E Carroll; Richard V Benya; Danielle Kim Turgeon; Shaiju Vareed; Malloree Neuman; Luz Rodriguez; Madhuri Kakarala; Philip M Carpenter; Christine McLaren; Frank L Meyskens; Dean E Brenner
Journal:  Cancer Prev Res (Phila)       Date:  2011-03

Review 2.  Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Authors:  Jayaraj Ravindran; Sahdeo Prasad; Bharat B Aggarwal
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

Review 3.  Ceramide signaling in the gut.

Authors:  Ying Li; Rebekah J Nicholson; Scott A Summers
Journal:  Mol Cell Endocrinol       Date:  2022-01-05       Impact factor: 4.102

4.  Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression.

Authors:  Dan Feng; Lena Ohlsson; Rui-Dong Duan
Journal:  Lipids Health Dis       Date:  2010-04-19       Impact factor: 3.876

5.  Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa.

Authors:  Grace G L Yue; Ben C L Chan; Po-Ming Hon; Mavis Y H Lee; Kwok-Pui Fung; Ping-Chung Leung; Clara B S Lau
Journal:  Food Chem Toxicol       Date:  2010-05-09       Impact factor: 6.023

6.  Polyisoprenylated methylated protein methyl esterase is both sensitive to curcumin and overexpressed in colorectal cancer: implications for chemoprevention and treatment.

Authors:  Felix Amissah; Randolph Duverna; Byron J Aguilar; Rosemary A Poku; Nazarius S Lamango
Journal:  Biomed Res Int       Date:  2013-07-01       Impact factor: 3.411

Review 7.  A neutraceutical by design: the clinical application of curcumin in colonic inflammation and cancer.

Authors:  D Soni; B Salh
Journal:  Scientifica (Cairo)       Date:  2012-09-03

Review 8.  Cancer Prevention and Therapy with Polyphenols: Sphingolipid-Mediated Mechanisms.

Authors:  Michele Dei Cas; Riccardo Ghidoni
Journal:  Nutrients       Date:  2018-07-21       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.